Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort

Study limitation reported by the research below: “The paper's DOI and publication date (July 2026) are future-dated relative to most current literature databases—confirm availability before citing.”